Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Allen, attorney, CFO, column, Compensia, decade, Doppelt, Doster, Drosdick, Dyer, Franklin, Gilchrist, IP, Kantor, Marshall, percent, Reed, Seton, Shorrock, treated, waited
Removed:
achieve, administrative, annually, approach, approval, automatic, basic, biologic, certification, collateral, commitment, Delaware, determination, determine, determining, develop, developing, devoted, discussed, embedded, establishment, expect, expected, forward, guidance, historical, impact, implement, Joint, measured, meet, part, preclinical, preliminary, principally, quantitative, reflect, relevant, renewal, renewed, significant, time, typically, understanding, unit, utilize, vesting, vitro, voluntarily
Filing tables
Filing exhibits
Associated APDN transcripts
APDN similar filings
Filing view
External links
Exhibit 31.4
CERTIFICATION PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, Beth Jantzen, certify that:
1. | I have reviewed this Amendment No. 2 to Annual Report on Form 10-K of Applied DNA Sciences, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: January 28, 2022
| /s/ Beth Jantzen |
| Beth Jantzen, CPA |
| Chief Financial Officer |
| (Principal Financial Officer) |